| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Nov―24 |
Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial |
Anil Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, Moti Ramgopal, Almena Free, Jennifer Han, et al. (+15) Jennifer Moore, Naomi Givens, Phillip J. Yates, Jill T. Walker, Mary Beth Connolly, Gretja Schnell, Varsha Imber, Rabia Anselm, Lindsay Winograd, Scott Segal, Stephen Harrison, Andrew Skingsley, Melissa Aldinger, Amanda Peppercorn, Jaynier Moya |
| 2 |
[GO] |
2022―Aug―25 |
Roxadustat for SARS-CoV-2 Infection: Old Signaling Raised New Hopes |
Luay Alkazmi, Hayder M. Al-kuraishy, Gaber El-Saber Batiha, Gomaa Mostafa-Hedeab, Michel De Waard, Jean-Marc Sabatier, et al. (+4) Saeed M. Kabrah, Hebatallah M. Saad, Ali I. Al-Gareeb, Jesus Simal-Gandara |
| 3 |
[GO] |
2022―Aug―24 |
Novel Strategies for the Treatment of COVID-19 |
Matthew W. McCarthy |
| 4 |
[GO] |
2021―Aug―05 |
Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2 |
Rosanne Sprute, Sofie Schumacher, Martina Pauls, Wolfgang Pauls, Oliver A. Cornely |
| 5 |
[GO] |
2021―Jul―29 |
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor |
Sajjan Rajpoot, Tomokazu Ohishi, Ashutosh Kumar, Qiuwei Pan, Sreeparna Banerjee, Kam Y. J. Zhang, Mirza S. Baig |
| 6 |
[GO] |
2021―Jun―21 |
Potential for the Repurposing of Adamantane Antivirals for COVID-19 |
Roger F. Butterworth |
| 7 |
[GO] |
2021―Jun―09 |
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies? |
Reinhart Speeckaert, Jo Lambert, Luis Puig, Marijn Speeckaert, Hilde Lapeere, Sofie De Schepper, Nanja van Geel |
| 8 |
[GO] |
2020―Dec―17 |
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment |
Fiona Marra, Elise J. Smolders, Omar El-Sherif, Alison Boyle, Katherine Davidson, Andrew J. Sommerville, et al. (+6) Catia Marzolini, Marco Siccardi, David Burger, Sara Gibbons, Saye Khoo, David Back |
| 9 |
[GO] |
2020―Dec―01 |
Dosing Considerations for Antibodies Against COVID-19 |
Million A. Tegenge, Iftekhar Mahmood, Evi Struble, Basil Golding |
| 10 |
[GO] |
2020―Jun―26 |
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells |
Mirza S. Baig, Manikandan Alagumuthu, Sajjan Rajpoot, Uzma Saqib |
|
